Table of Contents
From the Editor
- Exploring the human genome, and relearning genetics by necessity
The field of medical genetics continues to advance far beyond what many of us were exposed to in medical school.
The Clinical Picture
- High creatinine 6 months after renal transplant
Ultrasonography showed a large fluid collection compressing the transplanted kidney. What is the diagnosis?
- A 26-year-old woman with a lump in her chest
Computed tomography revealed a necrotic mass and bony destruction of the inferior sternum, but no pulmonary parenchymal lesions. What is the most likely diagnosis?
Review
- Putting genome analysis to good use: Lessons from C-reactive protein and cardiovascular disease
Genomics research is paying off, not only by identifying people at risk of rare inherited diseases, but also by clarifying the pathogenic mechanisms of common ones.
Addressing Disparities in Health Care
- Asthma in African Americans: What can we do about the higher rates of disease?
To remedy disparities such as greater disease severity and higher rates of hospitalization and death, we need to ensure that all patients receive proper care and the knowledge they need to control their asthma.
Review
- Endoscopic ultrasonography to evaluate pancreatitis
This test has become well accepted in the workup of acute and chronic pancreatitis. Further study is needed in recurrent acute pancreatitis and minimal-change chronic pancreatitis.
- Update on contraceptive options: A case-based discussion
Contraceptive counseling is both an art and a science. Here, the authors present several common scenarios.
Current Drug Therapy
Protease inhibitors: Silver bullets for chronic hepatitis C infection?These new drugs are a major step forward, and multidrug regimens that include them are the new standard of care.
Departments
- Cervical cancer screening (November 2011)
Readers comment on the oral anticoagulant dabigatran (October 2011), and screening for cervical cancer (November 2011).
- Dabigatran (October 2011)
Readers comment on the oral anticoagulant dabigatran (October 2011), and screening for cervical cancer (November 2011).
